Radiation therapy and combined modality treatment of gastrointestinal carcinomas

Cancer Treatment Reviews

Volumn 32, Issue 2, 2006, Pages 119-138

  Oehler, Christoph ^a   Ciernik, I Frank ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; BEVACIZUMAB; BLEOMYCIN; CAPECITABINE; CARBOPLATIN; CETUXIMAB; CISPLATIN; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; IRINOTECAN; MITOMYCIN; OXALIPLATIN; PACLITAXEL; TAXANE DERIVATIVE; VATALANIB; VINBLASTINE; VINDESINE;

ABDOMINAL RADIOTHERAPY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER SURVIVAL; CLINICAL TRIAL; COCHRANE LIBRARY; COLON CANCER; DRUG SAFETY; ESOPHAGEAL ADENOCARCINOMA; EXTERNAL BEAM RADIOTHERAPY; GASTROINTESTINAL CARCINOMA; GASTROINTESTINAL SURGERY; GASTROINTESTINAL TOXICITY; HEPATOBILIARY SYSTEM CANCER; HUMAN; INFORMATION PROCESSING; IONIZING RADIATION; MEDLINE; META ANALYSIS; MULTIMODALITY CANCER THERAPY; PANCREAS CANCER; POSTOPERATIVE CARE; PREOPERATIVE RADIOTHERAPY; RADIATION INJURY; RADIATION RESPONSE; RECTUM CANCER; STOMACH CANCER; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; GASTROINTESTINAL NEOPLASMS; HUMANS; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS;

EID: 33644842925     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctrv.2006.01.002     Document Type: Article

References (139)

1. C.A. Marijnen I.D. Nagtegaal E. Kapiteijn et. al. Radiotherapy does not compensate for positive resection margins in rectal cancer patients: report of a multicenter randomized trial Int J Radiat Oncol Biol Phys 55 2003 1311-1320
2. T. Conroy F. Bonnetain O. Chapet et. al. Preoperative (preop) radiotherapy (RT) + 5FU/folinic acid (FA) in T3,4 rectal cancers: preliminary results of the FFCD 9203 randomized trial J Clin Oncol 22 14S 2004 3626
3. R. Sauer H. Becker W. Hohenberger et. al. Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 2004 1731-1740
4. J.B. Hulscher J.W. van Sandick A.G. de Boer et. al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus N Engl J Med 347 2002 1662-1669
5. S.J. Arnott W. Duncan M. Gignoux et. al. Preoperative radiotherapy in esophageal carcinoma: A meta-analysis using individual patient data (Oesophageal Cancer Collaborative Group) Int J Radiat Oncol Biol Phys 41 1998 579-583
6. B. Launois D. Delarue J.P. Campion M. Kerbaol Preoperative radiotherapy for carcinoma of the esophagus Surg Gynecol Obstet 153 1981 690-692
7. M. Wang X.Z. Gu W.B. Yin G.J. Huang L.J. Wang D.W. Zhang Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of esophageal carcinoma: Report on 206 patients Int J Radiat Oncol Biol Phys 16 1989 325-327
8. M. Gignoux A. Roussel B. Paillot et. al. The value of preoperative radiotherapy in esophageal cancer: Results of a study of the E.O.R.T.C World J Surg 11 1987 426-432
9. K. Nygaard S. Hagen H.S. Hansen et. al. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer World J Surg 16 1992 1104-1109
10. D.P. Kelsen R. Ginsberg T.F. Pajak et. al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer N Engl J Med 339 1998 1979-1984
11. Medical Research Council Oesophageal Cancer Working G. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: A randomised controlled trial Lancet 359 2002 1727-1733
12. R. Malthaner D. Fenlon Preoperative chemotherapy for resectable thoracic esophageal cancer The Cochrane Library 2004
13. Phase III Randomized Study of Neoadjuvant Cisplatin and Fluorouracil Versus Cisplatin, Epirubicin, and Fluorouracil in Patients With Resectable Adenocarcinoma of the Esophagus. http://www.nci.nih.gov/ search/ViewClinicalTrials.aspx?cdrid= 69457&version= HealthProfessional&protocolsearchid=1145210.
14. P. Thirion Y. Piedbois J. Tierney et. al. Combined preoperative treatment in resectable esophageal carcinoma: Where do we stand? Proc Am Soc Clin Oncol 21 2002 133b
15. J.D. Urschel H. Vasan A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer Am J Surg 185 2003 538-543
16. F. Fiorica D. Di Bona F. Schepis et. al. Preoperative chemoradiotherapy for oesophageal cancer: A systematic review and meta-analysis Gut 53 2004 925-930
17. S.G. Urba M.B. Orringer A. Turrisi M. Iannettoni A. Forastiere M. Strawderman Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma J Clin Oncol 19 2001 305-313
18. T.N. Walsh N. Noonan D. Hollywood A. Kelly N. Keeling T.P. Hennessy A comparison of multimodal therapy and surgery for esophageal adenocarcinoma N Engl J Med 335 1996 462-467
19. C. Apinop P. Puttisak N. Preecha A prospective study of combined therapy in esophageal cancer Hepato-Gastroenterology 41 1994 391-393
20. B.H. Burmeister B.M. Smithers L. Fitzgerald et. al. A randomized phase III trial of preoperative chemoradiation followed by surgery (CR-S) versus surgery alone (S for localized resectable cancer of the esophagus) Proc Am Soc Clin Oncol 21 2002 130a
21. J.L. Lee S.B. Kim H.Y. Jung et. al. A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery (CRT-S) versus surgery (S) alone for stage II, III resectable esophageal squamous cell carcinoma (SCC): An interim analysis Proc Am Soc Clin Oncol 22 2003 260
22. J.F. Bosset M. Gignoux J.P. Triboulet et. al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus N Engl J Med 337 1997 161-167
23. E. Le Prise P.L. Etienne B. Meunier et. al. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus Cancer 73 1994 1779-1784
24. S. Urba M. Orringer A. Turrisi R. Whyte M. Iannettoni A. Forastiere A randomized trial comparing surgery to preoperative concomittant chemoradiation plus surgery in patients with resectable esophageal cancer. Update analysis Proc Am Soc Clin Oncol 16 1997 277a
25. Phase III Randomized Study of Neoadjuvant Radio-chemotherapy and Surgery Versus Surgery Alone in Patients With Resectable Thoracic Esophageal Cancer FFCD-9901. http://www.nci.nih.gov/search/ViewClinicalTrials. aspx?cdrid=257600&version=HealthProfessional&protocolsearchid= 1145210.
26. Phase II Study of Neoadjuvant Docetaxel and Cisplatin and Chemoradiotherapy Followed by Surgery in Patients With Locally Advanced, Resectable Esophageal Cancer. http://www.cancer.gov/search/ ViewClinicalTrials.aspx?cdrid= 335172&version=HealthProfessional&protocolsearchid=1231268.
27. M. Gibson B. Burtness E. Heath R. Heitmiller A.A. Forastiere Effect of neoadjuvant chemoradiotherapy on pathologic stage and survival in patients with locally advanced esophageal cancer J Clin Oncol 22 14S 2004 4032
28. J.A. Brooks E. Werner N.P. Jain et. al. A retrospective analysis to identify variables predictive of achieving a pCR after neoadjuvant chemoradiation therapy for locally advanced esophageal cancer J Clin Oncol 22 14S 2004 4061
29. N.I. Khushalani B.P. McKinley J.F. Gibbs C.G. Leichman N.J. Petrelli Regional chemotherapy is indicated after surgical resection of colorectal metastases to the liver: A debate J Surg Oncol 82 2003 65-72
30. L. Bedenne P. Michel O. Bouche et. al. Randomized phase III trial in locally advanced esophageal cancer: Radiochemotherapy followed by surgery versus radiochemotherapy alone (FFCD 9102) Proc Am Soc Clin Oncol 21 2002 130a
31. M. Stahl M. Stuschke N. Lehmann et. al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus J Clin Oncol 23 2005 2310-2317
32. M. al-Sarraf K. Martz A. Herskovic et. al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: An intergroup study J Clin Oncol 15 1997 277-284
33. J.S. Cooper M.D. Guo A. Herskovic et. al. Chemoradiotherapy of locally advanced esophagealcancer: Long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group JAMA 281 1999 1623-1627
34. B.D. Minsky T.F. Pajak R.J. Ginsberg et. al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: High-dose versus standard-dose radiation therapy J Clin Oncol 20 2002 1167-1174
35. R. Wong R. Malthaner Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus The Cochraine Library 2002
36. X.S. Gao X.Y. Qiao X.R. Yang et. al. Late course accelerated hyperfractionation radiotherapy concomitant with cisplatin in patients with esophageal carcinoma Oncol Rep 9 2002 767-772
37. J.R. Gray J.D. Hainsworth A.A Meluch et. al. Concurrent paclitaxel/ carboplatin/infusional 5-FU/radiation therapy (RT) with or without subsequent esophageal resection in patients with localized esophageal cancer: A Minnie Pearl Cancer Research Network trial J Clin Oncol 23 16S 2005 4018
38. P. Teniere J.M. Hay A. Fingerhut P.L. Fagniez Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. French University Association for Surgical Research Surg Gynecol Obstet 173 1991 123-130
39. H.U. Zieren J.M. Muller C.A. Jacobi H. Pichlmaier R.P. Muller S. Staar Adjuvant postoperative radiation therapy after curative resection of squamous cell carcinoma of the thoracic esophagus: A prospective randomized study World J Surg 19 1995 444-449
40. M. Fok J.S. Sham D. Choy S.W. Cheng J. Wong Postoperative radiotherapy for carcinoma of the esophagus: A prospective, randomized controlled study Surgery 113 1993 138-147
41. Z.F. Xiao Z.Y. Yang J. Liang et. al. Value of radiotherapy after radical surgery for esophageal carcinoma: A report of 495 patients Ann Thorac Surg 75 2003 331-336
42. N. Ando T. Iizuka H. Ide et. al. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: A Japan Clinical Oncology Group Study - JCOG9204 J Clin Oncol 21 2003 4592-4596
43. N. Ando T. Iizuka T. Kakegawa et. al. A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: The Japan Clinical Oncology Group Study J Thorac Cardiovasc Surg 114 1997 205-209
44. M. Tachibana H. Yoshimura S. Kinugasa et. al. Postoperative chemotherapy vs chemoradiotherapy for thoracic esophageal cancer: A prospective randomized clinical trial Eur J Surg Oncol 29 Sep 2003 580-587
45. Phase III Randomized Study of Adjuvant Chemoradiation After Resection in Patients With Gastric or Gastroesophageal Adenocarcinoma. http://www.nci.nih.gov/search/ViewClinicalTrials.aspx?cdrid= 258787&version=HealthProfessional&protocolsearchid=1145210.
46. J.S. Macdonald T.R. Fleming R.F. Peterson et. al. Adjuvant chemotherapy with 5-FU, adriamycin, and mitomycin-C (FAM) versus surgery alone for patients with locally advanced gastric adenocarcinoma: A Southwest Oncology Group study Ann Surg Oncol 2 1995 488-494
47. J.S. Macdonald S.R. Smalley J. Benedetti et. al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction N Engl J Med 345 2001 725-730
48. L.L. Gunderson Gastric cancer-patterns of relapse after surgical resection Semin Radiat Oncol 12 2002 150-161
49. H.H. Hartgrink C.J. van de Velde H. Putter et. al. Extended lymph node dissection for gastric cancer: Who may benefit? Final results of the randomized Dutch gastric cancer group trial J Clin Oncol 22 2004 2069-2077
50. A. Cuschieri S. Weeden J. Fielding et. al. Patient survival after D1 and D2 resections for gastric cancer: Long-term results of the MRC randomized surgical trial. Surgical Co-operative Group Br J Cancer 79 1999 1522-1530
51. T. Sano M. Sasako S. Yamamoto et. al. Gastric cancer surgery: Morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy - Japan Clinical Oncology Group study 9501 J Clin Oncol 22 2004 2767-2773
52. Z.X. Zhang X.Z. Gu W.B. Yin G.J. Huang D.W. Zhang R.G. Zhang Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of gastric cardia (AGC) - report on 370 patients Int J Radiat Oncol Biol Phys 42 1998 929-934
53. V.Y. Skoropad B.A. Berdov Y.S. Mardynski L.N. Titova A prospective, randomized trial of pre-operative and intraoperative radiotherapy versus surgery alone in resectable gastric cancer Eur J Surg Oncol 26 2000 773-779
54. A. Ajani P.F. Mansfield N. Janjan et. al. Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma J Clin Oncol 22 2004 2774-2780
55. J.A. Ajani R. Komaki J.B. Putnam et. al. A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction Cancer 92 2001 279-286
56. U. Fink C. Schuhmacher H.J. Stein et. al. Preoperative chemotherapy for stage III-IV gastric carcinoma: Feasibility, response and outcome after complete resection Br J Surg 82 1995 1248-1252
57. W. Allum D. Cunningham S. Weeden Perioperative chemotherapy in operable gastric and lower oesophageal cancer: A randomised, controlled trial (the MAGIC trial, ISRCTN 93793971) Proc Am Soc Clin Oncol 22 2003 249
58. D. Cunningham W. Allum S.P. Stenning S. Weeden Perioperative chemotherapy in operable gastric and lower oesophageal cancer: Final results of a randomised controlled trial (the MAGIC trial, ISRCTN 93793971) J Clin Oncol 23 16S 2005 4001
59. H. Hartgrink C.J. van de Velde H. Putter et. al. Neo-adjuvant chemotherapy for operable gastric cancer: Long term results of the Dutch randomised FAMTX trial Eur J Surg Oncol 30 August 2004 643-649
60. W.H. Allum M.T. Hallissey L.C. Ward M.S. Hockey A controlled, prospective, randomised trial of adjuvant chemotherapy or radiotherapy in resectable gastric cancer: Interim report. British Stomach Cancer Group Br J Cancer 60 1989 739-744
61. M.T. Hallissey J.A. Dunn L.C. Ward W.H. Allum The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: Five-year follow-up Lancet 343 1994 1309-1312
62. C.C. Earle J.A. Maroun Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: Revisiting a meta-analysis of randomised trials Eur J Cancer 35 1999 1059-1064
63. J. Hermans J.J. Bonenkamp M.C. Boon et. al. Adjuvant therapy after curative resection for gastric cancer: Meta-analysis of randomized trials J Clin Oncol 11 1993 1441-1447
64. J. Chipponi M. Huguier D. Pezet et. al. Randomized trial of adjuvant chemotherapy after curative resection for gastric cancer Am J Surg 187 2004 440-445
65. Phase III Randomized Study of Preoperative Versus Postoperative Chemotherapy With Docetaxel, Cisplatin, and Fluorouracil in Patients With Locally Advanced Operable Gastric Carcinoma. http://www.nci.nih.gov/ search/ViewClinicalTrials.aspx?cdrid=67658&version=HealthProfessional &protocolsearchid=1145216.
66. C.C. Earle J. Maroun L. Zuraw Neoadjuvant or adjuvant therapy for resectable gastric cancer? A practice guideline Can J Surg 45 2002 438-446
67. O. Bouche M. Ychou P. Burtin et. al. Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801) Ann Oncol 16 2005 1488-1497
68. E. Bajetta R. Buzzoni L. Mariani et. al. Adjuvant chemotherapy in gastric cancer: 5-year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group Ann Oncol 13 2002 299-307
69. Phase III Randomized Study of Adjuvant Chemoradiation After Resection in Patients With Gastric or Gastroesophageal Adenocarcinoma. http://wwwcancergov/search/ViewClinicalTrialsaspx?cdrid= 258787&version=HealthProfessional&protocolsearchid=1231223.
70. M. Imamura R. Doi T. Imaizumi et. al. A randomized multicenter trial comparing resection and radiochemotherapy for resectable locally invasive pancreatic cancer Surgery 136 2004 1003-1011
71. J.H. Klinkenbijl J. Jeekel T. Sahmoud et. al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: Phase III trial of the EORTC gastrointestinal tract cancer cooperative group Ann Surg 230 1999 776-782
72. T.M. Breslin K.R. Hess D.B. Harbison et. al. Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: Treatment variables and survival duration Ann Surg Oncol 8 2001 123-132
73. T.K. Pendurthi J.P. Hoffman E. Ross D.E. Johnson B.L. Eisenberg Preoperative versus postoperative chemoradiation for patients with resected pancreatic adenocarcinoma Am Surg 64 1998 686-692
74. G.R. Garton L.L. Gunderson D.M. Nagorney et. al. High-dose preoperative external beam and intraoperative irradiation for locally advanced pancreatic cancer Int J Radiat Oncol Biol Phys 27 1993 1153-1157
75. R.A. Wolff D.B. Evans C.H. Crane et. al. Initial results of preoperative gemcitabine (GEM)-based chemoradiation for resectable pancreatic adenocarcinoma Proc Am Soc Clin Oncol 21 2002 130a
76. Neoadjuvante Radiochemotherapie beim lokal sicher oder wahrscheinlich resektablen Pankreaskopfkarzinom ohne Fernmetastasen. http://www.studien.de/index.php.
77. Adjuvant postoperative intraarterial chemotherapy + radiotherapy (Arm A) vs. surgery alone (Arm B) in resectable ductal pancreatic cancer UICC I-III, IVa and advanced periampullary cancer. http://www.studien.de/ index.php.
78. M.H. Kalser S.S. Ellenberg Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection Arch Surg 120 1985 899-903
79. Gastrointestinal Tumor Study Group Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer Cancer 59 1987 2006-2010
80. R. Whittington M.P. Bryer D.G. Haller L.J. Solin E.F. Rosato Adjuvant therapy of resected adenocarcinoma of the pancreas Int J Radiat Oncol Biol Phys 21 1991 1137-1143
81. M.L. Foo L.L. Gunderson D.M. Nagorney et. al. Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation ±5 fluorouracil Int J Radiat Oncol Biol Phys 26 1993 483-489
82. C.J. Yeo R.A. Abrams L.B. Grochow et. al. Pancreaticoduodenectomy for pancreatic adenocarcinoma: Postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience Ann Surg 225 1997 621-633
83. A. Paulino Resected pancreatic cancer treated with adjuvant radiotherapy with or without 5-fluorouracil: Treatment results and patterns of failure Am J Clin Oncol 22 1999 489-494
84. C.G. Willett K. Lewandrowski A.L. Warshaw J. Efird C.C. Compton Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy Ann Surg 217 1993 144-148
85. Y. Nukui V.J. Picozzi L.W. Traverso Interferon-based adjuvant chemoradiation therapy improves survival after pancreaticoduodenectomy for pancreatic adenocarcinoma Am J Surg 179 2000 367-371
86. C.H. Crane J.L. Abbruzzese D.B. Evans et. al. Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer? Int J Radiat Oncol Biol Phys 52 2002 1293-1302
87. C. Li Y. Chao K.H. Chi et. al. Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: Gemcitabine versus 5-fluorouracil, a randomized controlled study Int J Radiat Oncol Biol Phys 57 2003 98-104
88. Phase II/III Randomized Study of Gemcitabine and Radiotherapy Versus Observation After Prior Curative Resection in Patients With Pancreatic Head Adenocarcinoma. http://www.nci.nih.gov/search/ViewClinicalTrials. aspx?cdrid=310131&version=HealthProfessional&protocolsearchid= 1140026.
89. V. Heinemann D. Quietzsch F.M. Gieseler et. al. A phase III trial comparing gemcitabine plus cisplatin vs. gemcitabine alone in advanced pancreatic carcinoma Proc Am Soc Clin Oncol 22 2003 250
90. S. Boeck A. Hinke R. Wilkowski V. Heinemann Analysis of prognostic factors in patients with advanced pancreatic cancer: Subgroup analysis of a randomized phase III trial comparing single-agent gemcitabine to the gemcitabine plus cisplatin combination J Clin Oncol 23 16S 2005 4105
91. J.P. Neoptolemos J.A. Dunn D.D. Stocken et. al. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: A randomised controlled trial Lancet 358 2001 1576-1585
92. J. Neoptolemos D.D. Stocken Friess et. al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer N Engl J Med 350 2004 1200-1210
93. K.E. Bakkevold B. Arnesjo O. Dahl B. Kambestad Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater - results of a controlled, prospective, randomised multicentre study Eur J Cancer 29A 1993 698-703
94. Phase III Randomized Adjuvant Study of Gemcitabine Versus Fluorouracil Leucovorin Calcium Versus Observation in Patients With Completely Resected Pancreatic Cancer. http://www.nci.nih.gov/search/ViewClinical Trials.aspx?cdrid=287023&version=HealthProfessional& protocolsearchid=1140026.
95. J.F. Bosset J.J. Pavy M. Gillet G. Mantion E. Pelissier S. Schraub Conventional external irradiation alone as adjuvant treatment in resectable pancreatic cancer: Results of a prospective study Radiother Oncol 24 1992 191-194
96. Y. Shibamoto T. Manabe N. Baba et. al. High dose, external beam and intraoperative radiotherapy in the treatment of resectable and unresectable pancreatic cancer Int J Radiat Oncol Biol Phys 19 1990 605-611
97. Y. Shibamoto T. Manabe G. Ohshio et. al. High-dose intraoperative radiotherapy for unresectable pancreatic cancer Int J Radiat Oncol Biol Phys 34 1996 57-63
98. J.E. Tepper D. Noyes J.M. Krall Intraoperative radiation therapy of pancreatic carcinoma: A report of RTOG-8505. Radiation Therapy Oncology Group Int J Radiat Oncol Biol Phys 21 1991 1145-1149
99. W.F. Sindelar T.J. Kinsella Studies of intraoperative radiotherapy in carcinoma of the pancreas Ann Oncol 10 Suppl 4 1999 226-230
100. N. Wolmark B. Fisher H. Rockette et. al. Postoperative adjuvant chemotherapy or BCG for colon cancer: Results from NSABP protocol C-01 J Natl Cancer Inst 80 1988 30-36
101. N. Wolmark H. Rockette B. Fisher et. al. The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: Results from National Surgical Adjuvant Breast and Bowel Project protocol C-03 J Clin Oncol 11 1993 1879-1887
102. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators. Lancet 1995;345:939-44.
103. M. Buyse P. Piedbois Should Dukes' B patients receive adjuvant therapy? A statistical perspective Semin Oncol 28 2001 20-24
104. E.A. Poplin J.K. Benedetti N.C. Estes et. al. Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer J Clin Oncol 23 2005 1819-1825
105. A. de Gramont C. Boni M. Navarro et. al. Oxaliplatin/5FU/LV in the adjuvant treatment of stage II and III colon cancer: Efficacy results with a median follow-up of 4 years J Clin Oncol 23 16S 2005 3501
106. E. Van Cutsem R. Labianca D. Hossfeld et. al. Randomized phase III trial comparing infused irinotecan/5-fluorouracil (5-FU)/folinic acid (IF) versus 5-FU/FA (F) in stage III colon cancer patients (pts) (PETACC 3) J Clin Oncol 23 16S 2005 LBA8
107. J.J. Martenson C.G. Willett D.J. Sargent et. al. Phase III study of adjuvant chemotherapy and radiation therapy compared with chemotherapy alone in the surgical adjuvant treatment of colon cancer: Results of intergroup protocol 0130 J Clin Oncol 22 2004 3277-3283
108. Colorectal Cancer Collaborative G. Adjuvant radiotherapy for rectal cancer: A systematic overview of 8507 patients from 22 randomised trials Lancet 358 2001 1291-1304
109. C. Camma M. Giunta F. Fiorica L. Pagliaro A. Craxi M. Cottone Preoperative radiotherapy for resectable rectal cancer: A meta-analysis JAMA 284 2000 1008-1015
110. G.J. Frykholm B. Glimelius L. Pahlman Preoperative or postoperative irradiation in adenocarcinoma of the rectum: Final treatment results of a randomized trial and an evaluation of late secondary effects Dis Colon Rectum 36 1993 564-572
111. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 1997;336:980-7.
112. E. Kapiteijn C.A. Marijnen I.D. Nagtegaal et. al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer N Engl J Med 345 2001 638-646
113. Y. Francois C.J. Nemoz J. Baulieux et. al. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: The Lyon R90-01 randomized trial J Clin Oncol 17 1999 2396
114. O. Glehen O. Chapet M. Adham J.C. Nemoz J.P. Gerard Long-term results of the Lyons R90-01 randomized trial of preoperative radiotherapy with delayed surgery and its effect on sphincter-saving surgery in rectal cancer Br J Surg 90 2003 996-998
115. K. Bujko M. Nowacki A. Nasierowska-Guttmejer et. al. Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy Radiother Oncol 72 2004 15-24
116. J. Gerard O. Chapet C. Nemoz et. al. Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: The Lyon R96-02 randomized trial J Clin Oncol 22 2004 2404-2409
117. S. Boulis-Wassif A. Gerard J. Loygue D. Camelot M. Buyse N. Duez Final results of a randomized trial on the treatment of rectal cancer with preoperative radiotherapy alone or in combination with 5-fluorouracil, followed by radical surgery. Trial of the European Organization on Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group Cancer 53 1984 1811-1818
118. J.F. Bosset G. Calais L. Mineur et. al. Preoperative radiation (Preop RT) in rectal cancer: Effect and timing of additional chemotherapy (CT) 5-year results of the EORTC 22921 trial J Clin Oncol 23 16S 2005 3505
119. J.F. Bosset G. Calais A. Daban et. al. Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: Assessment of acute toxicity and treatment compliance. Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group Eur J Cancer 40 2004 219-224
120. J.-F. Bosset G. Calais L. Mineur et. al. Does the addition of chemotherapy (CT) to preoperative radiotherapy (preopRT) increase the pathological response in patients with resected rectal cancer: Report of the 22921 EORTC phase III trial J Clin Oncol 14S 22 2004 3504
121. J. Gerard F. Bonnetain T. Conroy et. al. randomized trialPreoperative (preop) radiotherapy (RT) + 5 FU/folinic acid (FA) in T3-4 rectal cancers: Results of the FFCD 9203 J Clin Oncol 16S 23 2005 3504
122. Phase III Randomized Study of Preoperative Radiotherapy Versus Selective Postoperative Chemoradiotherapy in Patients With Operable Rectal Cancer. http://www.nci.nih.gov/search/ViewClinicalTrials.aspx?cdrid= 66442&version=HealthProfessional&protocolsearchid=1145255.
123. B. Fisher N. Wolmark H. Rockette et. al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: Results from NSABP protocol R-01 J Natl Cancer Inst 80 1988 21-29
124. D.M. Hyams E.P. Mamounas N. Petrelli et. al. A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum: A progress report of National Surgical Breast and Bowel Project Protocol R-03 Dis Colon Rectum 40 1997 131-139
125. Sauer R and the German Rectal Cancer Group. Adjuvant versus neoadjuvant combined modality treatment for locally advanced rectal cancer: First results of the German rectal cancer study (CAO/ARO/AIO-94). Int J Radiat Oncol Biol Phys 2003;57(Suppl 1):124-5.
126. J.F. Bosset G. Calais A. Daban et. al. Does the addition of chemotherapy to preoperative radiation increase acute toxicity in patients with rectal cancer: Report of 22921 EORTC phase III trial Proc Am Soc Clin Oncol 22 2003 294
127. C.H. Crane J.M. Skibber B.W. Feig et. al. Response to preoperative chemoradiation increases the use of sphincter-preserving surgery in patients with locally advanced low rectal carcinoma Cancer 97 2003 517-524
128. K. Wiltshire J. Brierley C. Swallow et. al. Preoperative radiation with concurrent chemotherapy for resectable rectal cancer: Effect of dose escalation on pathological complete response, local recurrence free survival & disease free survival Int J Radiat Oncol Biol Phys 60 Suppl 1 2004 293-294
129. P.R. Thomas A.S. Lindblad Adjuvant postoperative radiotherapy and chemotherapy in rectal carcinoma: A review of the Gastrointestinal Tumor Study Group experience Radiother Oncol 13 1988 245-252
130. J.E. Krook C.G. Moertel L.L. Gunderson et. al. Effective surgical adjuvant therapy for high-risk rectal carcinoma [comment] N Engl J Med 324 1991 709-715
131. M.J. O'Connell J.A. Martenson H.S. Wieand et. al. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery N Engl J Med 331 1994 502-507
132. F. Cafiero M. Gipponi R. Lionetto P.A.R.C.S. Group Randomised clinical trial of adjuvant postoperative RT vs. sequential postoperative RT plus 5-FU and levamisole in patients with stage II-III resectable rectal cancer: A final report J Surg Oncol 83 2003 140-146
133. N. Wolmark H.S. Wieand D.M. Hyams et. al. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02 J Natl Cancer Inst 92 2000 388-396
134. S.R. Smalley J. Benedetti S. Williamson et. al. Intergroup 0144: A phase III rectal surgical adjuvant study of pelvic radiation (XRT) plus 5-FU based chemotherapy (bolus 5-FU before and after PVI + XRT vs PVI before, during, and after XRT vs biochemically modulated bolus 5-FU and XRT): mature outcome results and pelvic failure analysis Int J Radiat Oncol Biol Phys 60 Suppl 1 2004 137-138
135. J.H. Lee J.H. Ahn H. Bahng et. al. Randomized trial of postoperative adjuvant therapy in stage II and III rectal cancer to define the optimal sequence of chemotherapy and radiotherapy: A preliminary report J Clin Oncol 20 2002 1751-1758
136. Phase III Randomized Study of Adjuvant Irinotecan, Fluorouracil, and Leucovorin Calcium Versus Oxaliplatin, Fluorouracil, and Leucovorin Calcium Versus Fluorouracil and Leucovorin Calcium in Patients With Stage II or III Rectal Cancer Receiving Combined Radiotherapy and Fluorouracil Either Preoperatively or Postoperatively. http://cancer.gov/ clinicaltrials/ECOG-E3201.
137. Sauer R. Adjuvante und neoadjuvante Radio-Chemotherapie des Rektumkarzinoms. Ergebnisse einer multizentrischen Phase-III-Studie (CAO/ ARO/AIO 94). Strahlenther Onkol 2003;Sondernummer 1: Abstract # 151 V.
138. Phase III Randomized Study of Preoperative Capecitabine and Radiotherapy Versus Fluorouracil and Radiotherapy in Patients With Resectable Rectal Cancer. http://www.nci.nih.gov/search/ViewClinicalTrials.aspx?cdrid= 298755&version=HealthProfessional&protocolsearchid=1145255.
139. M. Van de Vijver Y. He R. Bernards A gene-expression signature as a predictor of survival in breast cancer N Engl J Med 347 2002 1999-2009